JPRN-UMIN000049783已完成Unknown
A Randomized Parallel Group Trial to Evaluate the Impact of a Work Program Involving Snacks on Psychological Well-Being - A Randomized Parallel Group Trial to Evaluate the Impact of a Work Program Involving Snacks on Psychological Well-Being
Morinaga Seika Co. research institute0 个研究点目标入组 312 人开始时间: 2022年12月20日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 312
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Those who suffer from some kind of mental illness and are undergoing treatment. 2) Those who are allergic to eggs, milk, wheat, peanuts, or soybeans 3) Persons whose fasting blood glucose level is in the diabetic range (fasting blood glucose of 126 mg/dL or higher) 4) Persons who may change their lifestyle during the study period (night work, long trips, childbirth, marriage, etc.) 5) Persons who are recognized by the study sponsor as being incapable of cooperating in the study.
研究者
相似试验
招募中
1 期
A Randomized Parallel-Group Study to Evaluate the Efficacy and Safety of Immunotherapy for Idiopathic Cerebellar Ataxiaidiopathic cerebellar ataxiaJPRN-jRCTs031200250Yoshikura Nobuaki20
招募中
不适用
A Randomized Parallel-Group Study to Evaluate the Efficacy and Safety of I mmunotherapy for Idiopathic Cerebellar Ataxiaidiopathic cerebellar ataxiaJPRN-UMIN000046131Department of Neurology, Gifu University Hospital20
招募中
2 期
Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome2024-511922-30-00Crinetics Pharmaceuticals Inc.2
尚未招募
2 期
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome.E340 Carcinoid syndromeCarcinoid syndromeE340PER-049-22Crinetics Pharmaceuticals, Inc.
招募中
1 期
Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid SyndromeCarcinoid SyndromeMedDRA version: 20.0Level: PTClassification code: 10007270Term: Carcinoid syndrome Class: 100000004860CTIS2024-511922-30-00Crinetics Pharmaceuticals Inc.36